IL17A and Bloom syndrome: In the BLM model, Gr1+ neutrophils, activated by IL-1β and IL-17A signaling, produce B-cell activating factor (BAFF), which activates IL-17A+ T cells, further enhancing IL-17A expression and establishing a pro-fibrotic feedback loop (88).